Review





Similar Products

99
Advanced Cell Diagnostics Inc cd4
Cd4, supplied by Advanced Cell Diagnostics Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd4/CD4+Rabbit+Monoclonal+Antibody/pm42982037-183-63-80
Average 99 stars, based on 1 article reviews
cd4 - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

97
Miltenyi Biotec magnetic bead sorting kits
Magnetic Bead Sorting Kits, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd4/CD4%2B+T+Cell+Isolation+Kit%2C+mouse/pmc13747849-68-11-15
Average 97 stars, based on 1 article reviews
magnetic bead sorting kits - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

94
R&D Systems polyclonal goat anti human cd4 primary antibody
(A) HOS cells expressing CCR5 (R5 tropic virus; left), <t>HOS-CD4</t> + CCR5 + and HOS-CD4 - CCR5 + cells, or CXCR4 (X4 tropic virus; right) HOS-CD4 + CXCR4⁺ and HOS-CD4 - CXCR4 + cells. Cells were infected with luciferase reporter virus containing JR-FL env or HXB2-env respectively, and infection was quantified by luciferase activity at 48 hours post infection. <t>CD4-positive</t> cells served as controls for infection. Luciferase reagent only (Control) is shown for each condition. Each point represents the mean of three technical replicates per cell line. Data are representative of one of four independent biological replicates. (B) Western blot for CD4 showing a lack of CD4 protein detected in HOS cells as well as other epithelial cell lines, including 293 and HeLa while <t>T-cell</t> lines served as controls for CD4 protein expression. Results shown are from one representative experiment (n = 1). The original images are shown in . (C) Anti-CD4 blocking antibody inhibits CD4 + but not CD4 - HOS cell infection. Cells were pretreated for 1 hour with 2 µg/mL Ibalizumab, with vehicle control (water control) included. RLU was measured 48 hours post-infection and expressed as percent infection relative to vehicle control. Experiments were repeated twice; a representative result is shown. (D) RT-qPCR quantification of CD4 mRNA. Cq values plotted (lower Cq = higher expression); SupT1 (Cq = 27.2) and Raji (Cq = 38.2) served as positive/negative controls. Cq > 38.2 considered negative; Cq < 38.2 considered positive. Experiments were repeated twice; a representative result is shown.
Polyclonal Goat Anti Human Cd4 Primary Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd4/Human+CD4+Antibody/pmc13759070-94-10-18
Average 94 stars, based on 1 article reviews
polyclonal goat anti human cd4 primary antibody - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

97
Bio X Cell cd4 t cell depleting antibody
(A) HOS cells expressing CCR5 (R5 tropic virus; left), <t>HOS-CD4</t> + CCR5 + and HOS-CD4 - CCR5 + cells, or CXCR4 (X4 tropic virus; right) HOS-CD4 + CXCR4⁺ and HOS-CD4 - CXCR4 + cells. Cells were infected with luciferase reporter virus containing JR-FL env or HXB2-env respectively, and infection was quantified by luciferase activity at 48 hours post infection. <t>CD4-positive</t> cells served as controls for infection. Luciferase reagent only (Control) is shown for each condition. Each point represents the mean of three technical replicates per cell line. Data are representative of one of four independent biological replicates. (B) Western blot for CD4 showing a lack of CD4 protein detected in HOS cells as well as other epithelial cell lines, including 293 and HeLa while <t>T-cell</t> lines served as controls for CD4 protein expression. Results shown are from one representative experiment (n = 1). The original images are shown in . (C) Anti-CD4 blocking antibody inhibits CD4 + but not CD4 - HOS cell infection. Cells were pretreated for 1 hour with 2 µg/mL Ibalizumab, with vehicle control (water control) included. RLU was measured 48 hours post-infection and expressed as percent infection relative to vehicle control. Experiments were repeated twice; a representative result is shown. (D) RT-qPCR quantification of CD4 mRNA. Cq values plotted (lower Cq = higher expression); SupT1 (Cq = 27.2) and Raji (Cq = 38.2) served as positive/negative controls. Cq > 38.2 considered negative; Cq < 38.2 considered positive. Experiments were repeated twice; a representative result is shown.
Cd4 T Cell Depleting Antibody, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd4/InVivoMAb+anti-mouse+CD4/pm42962666-766-21-26
Average 97 stars, based on 1 article reviews
cd4 t cell depleting antibody - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

99
Zymo Research splenic cd4 t cells
(A) HOS cells expressing CCR5 (R5 tropic virus; left), <t>HOS-CD4</t> + CCR5 + and HOS-CD4 - CCR5 + cells, or CXCR4 (X4 tropic virus; right) HOS-CD4 + CXCR4⁺ and HOS-CD4 - CXCR4 + cells. Cells were infected with luciferase reporter virus containing JR-FL env or HXB2-env respectively, and infection was quantified by luciferase activity at 48 hours post infection. <t>CD4-positive</t> cells served as controls for infection. Luciferase reagent only (Control) is shown for each condition. Each point represents the mean of three technical replicates per cell line. Data are representative of one of four independent biological replicates. (B) Western blot for CD4 showing a lack of CD4 protein detected in HOS cells as well as other epithelial cell lines, including 293 and HeLa while <t>T-cell</t> lines served as controls for CD4 protein expression. Results shown are from one representative experiment (n = 1). The original images are shown in . (C) Anti-CD4 blocking antibody inhibits CD4 + but not CD4 - HOS cell infection. Cells were pretreated for 1 hour with 2 µg/mL Ibalizumab, with vehicle control (water control) included. RLU was measured 48 hours post-infection and expressed as percent infection relative to vehicle control. Experiments were repeated twice; a representative result is shown. (D) RT-qPCR quantification of CD4 mRNA. Cq values plotted (lower Cq = higher expression); SupT1 (Cq = 27.2) and Raji (Cq = 38.2) served as positive/negative controls. Cq > 38.2 considered negative; Cq < 38.2 considered positive. Experiments were repeated twice; a representative result is shown.
Splenic Cd4 T Cells, supplied by Zymo Research, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd4/DNA%2FRNA+Shield/pmc13759097-192-3-18
Average 99 stars, based on 1 article reviews
splenic cd4 t cells - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

91
Cytek Biosciences red fluor 710 cd4
Comparative biodistribution and immunomodulatory profiles of systemic versus targeted intra-arterial IL-10 administration post-reperfusion. a: Flow cytometric analysis of His-tag positive cells (His-tag + cells) in the blood in 6 h t-MCAO with normal saline (Placebo), 6 h t-MCAO with IL-10 IP (IL-10 IP), and 6 h t-MCAO with IL-10 IA (IL-10 IA). The percentages of the His-tag + cell subpopulations in the blood were shown. b: Quantification of His-tag + cells in Leukocytes. c and f: Flow cytometric analysis of Treg, IL-10, and neutrophil (Neut) subpopulation in the brain and blood. IL-10 producing cells were identified within the Treg population. Neuts were measured by CD11b + Ly6G + cells. d, e and g: Quantification of Treg, IL-10, and Neut in the brain. Data was analyzed by FlowJo; n = 6 per group. One-way ANOVA demonstrated significant differences with ∗p ≤ 0.05. ∗∗p ≤ 0.01. ∗∗∗p ≤ 0.001.
Red Fluor 710 Cd4, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd4/redFluor+710+Anti-Mouse+CD4/pmc13755943-74-38-42
Average 91 stars, based on 1 article reviews
red fluor 710 cd4 - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

97
Miltenyi Biotec manufacturing guidelines
Comparative biodistribution and immunomodulatory profiles of systemic versus targeted intra-arterial IL-10 administration post-reperfusion. a: Flow cytometric analysis of His-tag positive cells (His-tag + cells) in the blood in 6 h t-MCAO with normal saline (Placebo), 6 h t-MCAO with IL-10 IP (IL-10 IP), and 6 h t-MCAO with IL-10 IA (IL-10 IA). The percentages of the His-tag + cell subpopulations in the blood were shown. b: Quantification of His-tag + cells in Leukocytes. c and f: Flow cytometric analysis of Treg, IL-10, and neutrophil (Neut) subpopulation in the brain and blood. IL-10 producing cells were identified within the Treg population. Neuts were measured by CD11b + Ly6G + cells. d, e and g: Quantification of Treg, IL-10, and Neut in the brain. Data was analyzed by FlowJo; n = 6 per group. One-way ANOVA demonstrated significant differences with ∗p ≤ 0.05. ∗∗p ≤ 0.01. ∗∗∗p ≤ 0.001.
Manufacturing Guidelines, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd4/Naive+CD4%2B+T+Cell+Isolation+Kit%2C+mouse/bio_rxiv__64898__2026__10__31__763323-95-17-19
Average 97 stars, based on 1 article reviews
manufacturing guidelines - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

97
Bio X Cell mouse invivomab anti mouse cd4 antibody
Comparative biodistribution and immunomodulatory profiles of systemic versus targeted intra-arterial IL-10 administration post-reperfusion. a: Flow cytometric analysis of His-tag positive cells (His-tag + cells) in the blood in 6 h t-MCAO with normal saline (Placebo), 6 h t-MCAO with IL-10 IP (IL-10 IP), and 6 h t-MCAO with IL-10 IA (IL-10 IA). The percentages of the His-tag + cell subpopulations in the blood were shown. b: Quantification of His-tag + cells in Leukocytes. c and f: Flow cytometric analysis of Treg, IL-10, and neutrophil (Neut) subpopulation in the brain and blood. IL-10 producing cells were identified within the Treg population. Neuts were measured by CD11b + Ly6G + cells. d, e and g: Quantification of Treg, IL-10, and Neut in the brain. Data was analyzed by FlowJo; n = 6 per group. One-way ANOVA demonstrated significant differences with ∗p ≤ 0.05. ∗∗p ≤ 0.01. ∗∗∗p ≤ 0.001.
Mouse Invivomab Anti Mouse Cd4 Antibody, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd4/InVivoMAb+anti-mouse+CD4/pm42976205-101-16-23
Average 97 stars, based on 1 article reviews
mouse invivomab anti mouse cd4 antibody - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

99
Sony Biotechnology cd4 car tcd19 ngfr t cell pools
(A) Barcode level CD8 + log 2 fold change (Day 15 vs. Plasmid) values (red bars) for variants significantly enriched or de-enriched in the CD8 + screen. The grey gradient in the background shows the distribution of all barcodes in the CD8 + screen. (B) and (C) <t>CD4</t> + log 2 fold change relative to the frequency in the plasmid pool (Day −10) vs. time for bZIP variants significantly enriched (B) or de-enriched (C) in CD8 + <t>T</t> <t>cells.</t> Log 2 fold change fit by n = 2 donors, 2 replicates and calculated via DESeq2; significance calculated via Wald test in DESeq2. Open circles indicate timepoints with p adj < 0.05. (D) Barcode level CD4 + log 2 fold change (Day 15 vs. Plasmid) values (red bars) for variants significantly enriched or de-enriched in the CD8 + screen. The grey gradient in the background shows the distribution of all barcodes in the CD4 + screen. The results from one bZIP screen replicate on two donors are shown in (A) and (D).
Cd4 Car Tcd19 Ngfr T Cell Pools, supplied by Sony Biotechnology, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd4/SH800+Cell+Sorter/bio_rxiv__64898__2026__10__28__762687-339-3-15
Average 99 stars, based on 1 article reviews
cd4 car tcd19 ngfr t cell pools - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

97
Bio X Cell anti mouse cd4
(A) Barcode level CD8 + log 2 fold change (Day 15 vs. Plasmid) values (red bars) for variants significantly enriched or de-enriched in the CD8 + screen. The grey gradient in the background shows the distribution of all barcodes in the CD8 + screen. (B) and (C) <t>CD4</t> + log 2 fold change relative to the frequency in the plasmid pool (Day −10) vs. time for bZIP variants significantly enriched (B) or de-enriched (C) in CD8 + <t>T</t> <t>cells.</t> Log 2 fold change fit by n = 2 donors, 2 replicates and calculated via DESeq2; significance calculated via Wald test in DESeq2. Open circles indicate timepoints with p adj < 0.05. (D) Barcode level CD4 + log 2 fold change (Day 15 vs. Plasmid) values (red bars) for variants significantly enriched or de-enriched in the CD8 + screen. The grey gradient in the background shows the distribution of all barcodes in the CD4 + screen. The results from one bZIP screen replicate on two donors are shown in (A) and (D).
Anti Mouse Cd4, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd4/InVivoMAb+anti-mouse+CD4/pm42957863-1096-11-15
Average 97 stars, based on 1 article reviews
anti mouse cd4 - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

Image Search Results


(A) HOS cells expressing CCR5 (R5 tropic virus; left), HOS-CD4 + CCR5 + and HOS-CD4 - CCR5 + cells, or CXCR4 (X4 tropic virus; right) HOS-CD4 + CXCR4⁺ and HOS-CD4 - CXCR4 + cells. Cells were infected with luciferase reporter virus containing JR-FL env or HXB2-env respectively, and infection was quantified by luciferase activity at 48 hours post infection. CD4-positive cells served as controls for infection. Luciferase reagent only (Control) is shown for each condition. Each point represents the mean of three technical replicates per cell line. Data are representative of one of four independent biological replicates. (B) Western blot for CD4 showing a lack of CD4 protein detected in HOS cells as well as other epithelial cell lines, including 293 and HeLa while T-cell lines served as controls for CD4 protein expression. Results shown are from one representative experiment (n = 1). The original images are shown in . (C) Anti-CD4 blocking antibody inhibits CD4 + but not CD4 - HOS cell infection. Cells were pretreated for 1 hour with 2 µg/mL Ibalizumab, with vehicle control (water control) included. RLU was measured 48 hours post-infection and expressed as percent infection relative to vehicle control. Experiments were repeated twice; a representative result is shown. (D) RT-qPCR quantification of CD4 mRNA. Cq values plotted (lower Cq = higher expression); SupT1 (Cq = 27.2) and Raji (Cq = 38.2) served as positive/negative controls. Cq > 38.2 considered negative; Cq < 38.2 considered positive. Experiments were repeated twice; a representative result is shown.

Journal: PLOS One

Article Title: A cell line model for the study of CD4-negative HIV-1 infection and latent virus reservoirs

doi: 10.1371/journal.pone.0361655

Figure Lengend Snippet: (A) HOS cells expressing CCR5 (R5 tropic virus; left), HOS-CD4 + CCR5 + and HOS-CD4 - CCR5 + cells, or CXCR4 (X4 tropic virus; right) HOS-CD4 + CXCR4⁺ and HOS-CD4 - CXCR4 + cells. Cells were infected with luciferase reporter virus containing JR-FL env or HXB2-env respectively, and infection was quantified by luciferase activity at 48 hours post infection. CD4-positive cells served as controls for infection. Luciferase reagent only (Control) is shown for each condition. Each point represents the mean of three technical replicates per cell line. Data are representative of one of four independent biological replicates. (B) Western blot for CD4 showing a lack of CD4 protein detected in HOS cells as well as other epithelial cell lines, including 293 and HeLa while T-cell lines served as controls for CD4 protein expression. Results shown are from one representative experiment (n = 1). The original images are shown in . (C) Anti-CD4 blocking antibody inhibits CD4 + but not CD4 - HOS cell infection. Cells were pretreated for 1 hour with 2 µg/mL Ibalizumab, with vehicle control (water control) included. RLU was measured 48 hours post-infection and expressed as percent infection relative to vehicle control. Experiments were repeated twice; a representative result is shown. (D) RT-qPCR quantification of CD4 mRNA. Cq values plotted (lower Cq = higher expression); SupT1 (Cq = 27.2) and Raji (Cq = 38.2) served as positive/negative controls. Cq > 38.2 considered negative; Cq < 38.2 considered positive. Experiments were repeated twice; a representative result is shown.

Article Snippet: The gel was transferred to nitrocellulose membrane and probed with polyclonal goat anti-human CD4 primary antibody (Novus Biologicals, R&D Systems #AF-379-NA, Lot #YS0819111) and protein visualized using rabbit anti-goat HRP (Novus Biologicals) and enhanced chemiluminescence.

Techniques: Expressing, Virus, Infection, Luciferase, Activity Assay, Control, Western Blot, Blocking Assay, Quantitative RT-PCR

Summary of flow cytometry results for the cell-surface expression of  CD4,  CXCR4 and CCR5 on HOS cells (see <xref ref-type= S2 Fig for flow data)." width="100%" height="100%">

Journal: PLOS One

Article Title: A cell line model for the study of CD4-negative HIV-1 infection and latent virus reservoirs

doi: 10.1371/journal.pone.0361655

Figure Lengend Snippet: Summary of flow cytometry results for the cell-surface expression of CD4, CXCR4 and CCR5 on HOS cells (see S2 Fig for flow data).

Article Snippet: The gel was transferred to nitrocellulose membrane and probed with polyclonal goat anti-human CD4 primary antibody (Novus Biologicals, R&D Systems #AF-379-NA, Lot #YS0819111) and protein visualized using rabbit anti-goat HRP (Novus Biologicals) and enhanced chemiluminescence.

Techniques: Flow Cytometry, Expressing

Cells were infected with the HIV-1 GFP reporter virus and imaged at 72 hours post-infection using fluorescence microscopy. A substantially higher population of GFP-positive cells was observed in the CD4-positive group compared to the CD4-negative cells. Notably, GFP expression in CD4-negative cells confirms viral integration, demonstrating that these cells support HIV-1 infection. Experiments were repeated 3 times; a representative result is shown.

Journal: PLOS One

Article Title: A cell line model for the study of CD4-negative HIV-1 infection and latent virus reservoirs

doi: 10.1371/journal.pone.0361655

Figure Lengend Snippet: Cells were infected with the HIV-1 GFP reporter virus and imaged at 72 hours post-infection using fluorescence microscopy. A substantially higher population of GFP-positive cells was observed in the CD4-positive group compared to the CD4-negative cells. Notably, GFP expression in CD4-negative cells confirms viral integration, demonstrating that these cells support HIV-1 infection. Experiments were repeated 3 times; a representative result is shown.

Article Snippet: The gel was transferred to nitrocellulose membrane and probed with polyclonal goat anti-human CD4 primary antibody (Novus Biologicals, R&D Systems #AF-379-NA, Lot #YS0819111) and protein visualized using rabbit anti-goat HRP (Novus Biologicals) and enhanced chemiluminescence.

Techniques: Infection, Virus, Fluorescence, Microscopy, Expressing

HOS cells were infected with luciferase reporter viruses in the presence of coreceptor antagonists or with non-enveloped virus. (A)Top: Infection of HOS-CCR5 + cells with maraviroc and raltegravir & Bottom: Infection of HOS-CXCR4 + cells with Plerixafor (AMD3100) and raltegravir. Cells were pretreated for 1 hour with either 1 µM raltegravir, 1 µM maraviroc, 1 µM AMD3100 or with vehicle control (0.1% DMSO) included. RLU was measured 48 hours post-infection and expressed as percent infection relative to vehicle controls. Vehicle control yielded readouts of 3.2 × 10 7 RLU (CD4-positive) and 3.7 × 10 4 RLU (CD4-negative) in Top, and 4.2 × 10 6 RLU (CD4-positive) and 9.0 × 10 4 RLU (CD4-negative) in Bottom. In CD4-positive cells, raltegravir, maraviroc, and AMD3100 all produced significant inhibition. Raltegravir achieved near-complete inhibition in CD4-negative cells, and AMD3100 reduced infection in CD4-negative X4 cells by ~50%. Data are representative of one biological replicate; each condition was tested in 3–6 technical replicates, with the number of independent experiments as follows: Raltegravir, n = 4; AMD3100, n = 1; Maraviroc, n = 2. (B) HOS-CD4 + CCR5 + and HOS-CD4 - CCR5 + cells (Top) and HOS-CD4 + CXCR4⁺ and HOS-CD4 - CXCR4 + cells (Bottom). Cells were infected with HIV-1 luciferase reporter virus containing HIV-1 envelope (Env) or lacking envelope (Non-Env). 48 hours post infection RLU was measured. “No virus” wells (cells plus reagents, no virus) served as negative controls. Data are presented as luciferase activity. Representative data from one of two independent biological experiments, each performed with 3–6 technical replicates per condition. Significantly higher infection was observed in CD4-positive cells exposed to envelope-containing virus compared to envelope-deficient controls. In CD4-negative R5 cells (Top right), there was no significant difference in the level of infection with or without the envelope added. CD4-negative X4 cells (Bottom right) indicated a significantly higher level of infection with the addition of envelope demonstrating that HIV-1 infection in these CD4-negative cells is envelope-dependent.

Journal: PLOS One

Article Title: A cell line model for the study of CD4-negative HIV-1 infection and latent virus reservoirs

doi: 10.1371/journal.pone.0361655

Figure Lengend Snippet: HOS cells were infected with luciferase reporter viruses in the presence of coreceptor antagonists or with non-enveloped virus. (A)Top: Infection of HOS-CCR5 + cells with maraviroc and raltegravir & Bottom: Infection of HOS-CXCR4 + cells with Plerixafor (AMD3100) and raltegravir. Cells were pretreated for 1 hour with either 1 µM raltegravir, 1 µM maraviroc, 1 µM AMD3100 or with vehicle control (0.1% DMSO) included. RLU was measured 48 hours post-infection and expressed as percent infection relative to vehicle controls. Vehicle control yielded readouts of 3.2 × 10 7 RLU (CD4-positive) and 3.7 × 10 4 RLU (CD4-negative) in Top, and 4.2 × 10 6 RLU (CD4-positive) and 9.0 × 10 4 RLU (CD4-negative) in Bottom. In CD4-positive cells, raltegravir, maraviroc, and AMD3100 all produced significant inhibition. Raltegravir achieved near-complete inhibition in CD4-negative cells, and AMD3100 reduced infection in CD4-negative X4 cells by ~50%. Data are representative of one biological replicate; each condition was tested in 3–6 technical replicates, with the number of independent experiments as follows: Raltegravir, n = 4; AMD3100, n = 1; Maraviroc, n = 2. (B) HOS-CD4 + CCR5 + and HOS-CD4 - CCR5 + cells (Top) and HOS-CD4 + CXCR4⁺ and HOS-CD4 - CXCR4 + cells (Bottom). Cells were infected with HIV-1 luciferase reporter virus containing HIV-1 envelope (Env) or lacking envelope (Non-Env). 48 hours post infection RLU was measured. “No virus” wells (cells plus reagents, no virus) served as negative controls. Data are presented as luciferase activity. Representative data from one of two independent biological experiments, each performed with 3–6 technical replicates per condition. Significantly higher infection was observed in CD4-positive cells exposed to envelope-containing virus compared to envelope-deficient controls. In CD4-negative R5 cells (Top right), there was no significant difference in the level of infection with or without the envelope added. CD4-negative X4 cells (Bottom right) indicated a significantly higher level of infection with the addition of envelope demonstrating that HIV-1 infection in these CD4-negative cells is envelope-dependent.

Article Snippet: The gel was transferred to nitrocellulose membrane and probed with polyclonal goat anti-human CD4 primary antibody (Novus Biologicals, R&D Systems #AF-379-NA, Lot #YS0819111) and protein visualized using rabbit anti-goat HRP (Novus Biologicals) and enhanced chemiluminescence.

Techniques: Infection, Luciferase, Virus, Control, Produced, Inhibition, Activity Assay

(A) Schematic and gating strategy for the HI.fate dual‑fluorescent reporter system. HI.fate is derived from the HIV‑1 NL4‑3 molecular clone with defective env and vpr genes . E2‑Crimson is expressed from the HIV‑1 LTR and marks active viral gene expression (productively infected/replicating cells), whereas ZsGreen is expressed from an internal constitutive promoter and marks cells that have undergone HIV‑1 entry and proviral integration (all infected cells). In representative two‑parameter plots of E2‑Crimson versus ZsGreen fluorescence, quadrants were defined as follows: Q1 (double‑negative), uninfected cells; Q2 + Q3; E2‑Crimson⁺ with or without ZsGreen, productively infected cells; Q4; ZsGreen⁺ only, latently infected cells . HOS- CD4 + CXCR4 + and HOS-CD4 - CXCR4 + cells were infected with HXB2-pseudotyped HI.fate.E virus. Cells were acquired for flow cytometry analysis 72 hours post infection. Representative data from one of three independent biological experiments as shown. Panels B and C (top) show no‑virus controls used to define background fluorescence and gating thresholds. (B) In CD4 + CXCR4 + cells (bottom), 2.3% of cells were productively infected (P5) and 0.4% were latently infected. (C) In CD4 - CXCR4 + cells (bottom), 0.06% of cells were productively infected and 0.02% were latently infected. Data shown are presented as percentages of total live, single cells. was created using BioRender.com.

Journal: PLOS One

Article Title: A cell line model for the study of CD4-negative HIV-1 infection and latent virus reservoirs

doi: 10.1371/journal.pone.0361655

Figure Lengend Snippet: (A) Schematic and gating strategy for the HI.fate dual‑fluorescent reporter system. HI.fate is derived from the HIV‑1 NL4‑3 molecular clone with defective env and vpr genes . E2‑Crimson is expressed from the HIV‑1 LTR and marks active viral gene expression (productively infected/replicating cells), whereas ZsGreen is expressed from an internal constitutive promoter and marks cells that have undergone HIV‑1 entry and proviral integration (all infected cells). In representative two‑parameter plots of E2‑Crimson versus ZsGreen fluorescence, quadrants were defined as follows: Q1 (double‑negative), uninfected cells; Q2 + Q3; E2‑Crimson⁺ with or without ZsGreen, productively infected cells; Q4; ZsGreen⁺ only, latently infected cells . HOS- CD4 + CXCR4 + and HOS-CD4 - CXCR4 + cells were infected with HXB2-pseudotyped HI.fate.E virus. Cells were acquired for flow cytometry analysis 72 hours post infection. Representative data from one of three independent biological experiments as shown. Panels B and C (top) show no‑virus controls used to define background fluorescence and gating thresholds. (B) In CD4 + CXCR4 + cells (bottom), 2.3% of cells were productively infected (P5) and 0.4% were latently infected. (C) In CD4 - CXCR4 + cells (bottom), 0.06% of cells were productively infected and 0.02% were latently infected. Data shown are presented as percentages of total live, single cells. was created using BioRender.com.

Article Snippet: The gel was transferred to nitrocellulose membrane and probed with polyclonal goat anti-human CD4 primary antibody (Novus Biologicals, R&D Systems #AF-379-NA, Lot #YS0819111) and protein visualized using rabbit anti-goat HRP (Novus Biologicals) and enhanced chemiluminescence.

Techniques: Derivative Assay, Gene Expression, Infection, Fluorescence, Virus, Flow Cytometry, Analysis

Comparative biodistribution and immunomodulatory profiles of systemic versus targeted intra-arterial IL-10 administration post-reperfusion. a: Flow cytometric analysis of His-tag positive cells (His-tag + cells) in the blood in 6 h t-MCAO with normal saline (Placebo), 6 h t-MCAO with IL-10 IP (IL-10 IP), and 6 h t-MCAO with IL-10 IA (IL-10 IA). The percentages of the His-tag + cell subpopulations in the blood were shown. b: Quantification of His-tag + cells in Leukocytes. c and f: Flow cytometric analysis of Treg, IL-10, and neutrophil (Neut) subpopulation in the brain and blood. IL-10 producing cells were identified within the Treg population. Neuts were measured by CD11b + Ly6G + cells. d, e and g: Quantification of Treg, IL-10, and Neut in the brain. Data was analyzed by FlowJo; n = 6 per group. One-way ANOVA demonstrated significant differences with ∗p ≤ 0.05. ∗∗p ≤ 0.01. ∗∗∗p ≤ 0.001.

Journal: Neurotherapeutics

Article Title: Reperfusion enhances treg-mediated neuroprotection and IL-10 signaling in a mouse model of large vessel occlusion

doi: 10.1016/j.neurot.2026.e01110

Figure Lengend Snippet: Comparative biodistribution and immunomodulatory profiles of systemic versus targeted intra-arterial IL-10 administration post-reperfusion. a: Flow cytometric analysis of His-tag positive cells (His-tag + cells) in the blood in 6 h t-MCAO with normal saline (Placebo), 6 h t-MCAO with IL-10 IP (IL-10 IP), and 6 h t-MCAO with IL-10 IA (IL-10 IA). The percentages of the His-tag + cell subpopulations in the blood were shown. b: Quantification of His-tag + cells in Leukocytes. c and f: Flow cytometric analysis of Treg, IL-10, and neutrophil (Neut) subpopulation in the brain and blood. IL-10 producing cells were identified within the Treg population. Neuts were measured by CD11b + Ly6G + cells. d, e and g: Quantification of Treg, IL-10, and Neut in the brain. Data was analyzed by FlowJo; n = 6 per group. One-way ANOVA demonstrated significant differences with ∗p ≤ 0.05. ∗∗p ≤ 0.01. ∗∗∗p ≤ 0.001.

Article Snippet: Cells were washed and incubated with mouse Fc-receptor blocker (1:50, BioLegend, Cat# 101320) to prevent non-specific binding and stained with APC-CY7-CD11b (1:100, BioLegend, Cat# 101226), PE-CD45.1 (1:100, TONBO biosciences, Cat#50-0453), Violet Fluor 450- Ly6G (1:100, TONBO biosciences, Cat#75-1276), Red Fluor 710-CD4 (1:100, TONBO biosciences, Cat#80-0041), PE/Dazzle 594-CD25 (1:100, BioLegend, Cat# 101920) using fluorophore-conjugated monoclonal antibodies.

Techniques: Analysis, Saline

(A) Barcode level CD8 + log 2 fold change (Day 15 vs. Plasmid) values (red bars) for variants significantly enriched or de-enriched in the CD8 + screen. The grey gradient in the background shows the distribution of all barcodes in the CD8 + screen. (B) and (C) CD4 + log 2 fold change relative to the frequency in the plasmid pool (Day −10) vs. time for bZIP variants significantly enriched (B) or de-enriched (C) in CD8 + T cells. Log 2 fold change fit by n = 2 donors, 2 replicates and calculated via DESeq2; significance calculated via Wald test in DESeq2. Open circles indicate timepoints with p adj < 0.05. (D) Barcode level CD4 + log 2 fold change (Day 15 vs. Plasmid) values (red bars) for variants significantly enriched or de-enriched in the CD8 + screen. The grey gradient in the background shows the distribution of all barcodes in the CD4 + screen. The results from one bZIP screen replicate on two donors are shown in (A) and (D).

Journal: bioRxiv

Article Title: A network of bZIP transcription factors and inhibitors enforces differentially proliferative and cytotoxic states in T cells

doi: 10.64898/2026.10.28.762687

Figure Lengend Snippet: (A) Barcode level CD8 + log 2 fold change (Day 15 vs. Plasmid) values (red bars) for variants significantly enriched or de-enriched in the CD8 + screen. The grey gradient in the background shows the distribution of all barcodes in the CD8 + screen. (B) and (C) CD4 + log 2 fold change relative to the frequency in the plasmid pool (Day −10) vs. time for bZIP variants significantly enriched (B) or de-enriched (C) in CD8 + T cells. Log 2 fold change fit by n = 2 donors, 2 replicates and calculated via DESeq2; significance calculated via Wald test in DESeq2. Open circles indicate timepoints with p adj < 0.05. (D) Barcode level CD4 + log 2 fold change (Day 15 vs. Plasmid) values (red bars) for variants significantly enriched or de-enriched in the CD8 + screen. The grey gradient in the background shows the distribution of all barcodes in the CD4 + screen. The results from one bZIP screen replicate on two donors are shown in (A) and (D).

Article Snippet: Live CD8 and CD4 CAR(tCD19) + NGFR + T cell pools were collected using a Sony SH800 on day −4 (day 6 of expansion), 0, 9, and 15 of the coculture.

Techniques: Plasmid Preparation

(A) Fold-change expansion of TF-overexpressing CAR T cells; n = 4-5 donors; error bars show SD; significance calculated via two-way ANOVA with Tukey’s test for multiple comparisons; **** p < 0.0001, *** p < 0.001 (B) Fold-change residual tumor relative to the tumor cells added for each round of stimulation; n = 5 donors; error bars show SD (C) Frequency of TNF-α + , IFN-γ + , GNLY + , and IL-2 + TF-overexpressing GD2 CAR T cells at baseline and after 3 rounds of chronic tumor cell stimulation; n = 4-5 donors; error bars show SD; significance calculated via one-way ANOVA with Dunnett’s test for multiple comparisons; **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05. (D) UMAPs for paired BATF2 conditions per timepoint. Pie charts display the frequency of each FLOWSOM cluster. Cluster colors are the same as in . (E) Frequency of CD25 + cells for CD8+ (left) and CD4+ (right) GD2 CAR T cells in coculture; n = 5 donors; error bars show SD; significance calculated via two-way ANOVA with Dunnett’s multiple comparison’s test; **** p < 0.0001, *** p < 0.001. (F) Overall frequency of CD4 + BATF2-overexpressing GD2 CAR T cells in coculture (G) Expression of select markers in BATF2-overexpressing and CAR.tNGFR T cells in coculture; n = 5 donors; error bars show SD; significance calculated via mixed-effects model for the effect of condition; *** p < 0.001. (H) CCR7 + frequency in CD8 + CAR.BATF2 and CAR.tNGFR T cells (I) Fold-change expansion of TF-overexpressing GD2 CAR T cells cultured with or without IL-7 and IL-15 for 7 days

Journal: bioRxiv

Article Title: A network of bZIP transcription factors and inhibitors enforces differentially proliferative and cytotoxic states in T cells

doi: 10.64898/2026.10.28.762687

Figure Lengend Snippet: (A) Fold-change expansion of TF-overexpressing CAR T cells; n = 4-5 donors; error bars show SD; significance calculated via two-way ANOVA with Tukey’s test for multiple comparisons; **** p < 0.0001, *** p < 0.001 (B) Fold-change residual tumor relative to the tumor cells added for each round of stimulation; n = 5 donors; error bars show SD (C) Frequency of TNF-α + , IFN-γ + , GNLY + , and IL-2 + TF-overexpressing GD2 CAR T cells at baseline and after 3 rounds of chronic tumor cell stimulation; n = 4-5 donors; error bars show SD; significance calculated via one-way ANOVA with Dunnett’s test for multiple comparisons; **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05. (D) UMAPs for paired BATF2 conditions per timepoint. Pie charts display the frequency of each FLOWSOM cluster. Cluster colors are the same as in . (E) Frequency of CD25 + cells for CD8+ (left) and CD4+ (right) GD2 CAR T cells in coculture; n = 5 donors; error bars show SD; significance calculated via two-way ANOVA with Dunnett’s multiple comparison’s test; **** p < 0.0001, *** p < 0.001. (F) Overall frequency of CD4 + BATF2-overexpressing GD2 CAR T cells in coculture (G) Expression of select markers in BATF2-overexpressing and CAR.tNGFR T cells in coculture; n = 5 donors; error bars show SD; significance calculated via mixed-effects model for the effect of condition; *** p < 0.001. (H) CCR7 + frequency in CD8 + CAR.BATF2 and CAR.tNGFR T cells (I) Fold-change expansion of TF-overexpressing GD2 CAR T cells cultured with or without IL-7 and IL-15 for 7 days

Article Snippet: Live CD8 and CD4 CAR(tCD19) + NGFR + T cell pools were collected using a Sony SH800 on day −4 (day 6 of expansion), 0, 9, and 15 of the coculture.

Techniques: Cell Stimulation, Expressing, Cell Culture